Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis
Clinical trial NCT04313400 · COMPLETED
Trial details
- NCT number
- NCT04313400
- Sponsor
- Amytrx Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2023-12-19
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.